Document is current
Any future updates will be listed below
-
Authors
Schattgen, Stefan A. https://orcid.org/0000-0002-6860-5079
Guion, Kate https://orcid.org/0000-0002-3859-7573
Crawford, Jeremy Chase https://orcid.org/0000-0003-4096-6048
Souquette, Aisha
Barrio, Alvaro Martinez https://orcid.org/0000-0001-5064-2093
Stubbington, Michael J. T.
Thomas, Paul G. https://orcid.org/0000-0001-7955-0256
Bradley, Philip https://orcid.org/0000-0002-0224-6464
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (R01 AI136514)
American Lebanese Syrian Associated Charities
- License Information
-
More Information
Article History
Received: 7 August 2020
Accepted: 18 June 2021
First Online: 23 August 2021
Competing interests
: M.J.T.S. is employed by 10x Genomics. M.J.T.S., A.M.B. and J.C.C. are option or shareholders of 10x Genomics. P.B., P.G.T. and J.C.C. served as unpaid consultants for 10x Genomics on the initial data analysis of the 10x_200k dataset. P.G.T. has filed patents related to the cloning, expression and characterization of T cell receptors. P.G.T. has received travel or speaking expenses from 10x Genomics, Illumina and PACT Pharma.
